Business ❯ Pharmaceutical Industry

Licensing Agreements

Financial Transactions Strategic Partnerships Partnerships Collaborations Lupin Pharmaceuticals Co-Marketing Drug Development Market Competition Global Collaborations Market Authorization Drug Commercialization Biotechnology Market Expansion International Deals Collaboration Agreements Drug Partnerships Clinical Development Eurofarma International Partnerships Collaboration Generic Production

Pfizer to Commercialize Sciwind’s GLP-1 Ecnoglutide in China Under Exclusive License

The tie-up signals Pfizer’s push into metabolic therapies in a competitive Chinese market.

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

Novo Nordisk Licenses Omeros’ MASP-3 Drug in Deal Worth Up to $2.1 Billion

GSK Closes $12 Billion Licensing Pact for Hengrui’s COPD Therapy and 11 Preclinical Assets